Ceo
CurrentAs CEO I am responsible for developing the company as a high quality provider of Drug Discovery specialty services and developing the commercialization strategy together with the Board.
Please complete the CAPTCHA to continue
@pelagobio.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Michael Dabrowski is listed as CEO at Pelago Bioscience AB at Pelago Bioscience AB, based in Nacka, Stockholm County, Sweden. AeroLeads shows a work email signal at pelagobio.com and a matched LinkedIn profile for Michael Dabrowski.
Michael Dabrowski previously worked as CEO at Pelago Bioscience Ab and Co-Founder at Pelago Bioscience Ab. Michael Dabrowski holds Executive Leadership Programme, Business Administration And Management, General from Stockholm School Of Economics.
This section adds company-level context without repeating Michael Dabrowski's masked contact details.
AeroLeads found 1 current-domain work email signal for Michael Dabrowski. Compare company email patterns before reaching out.
More than 25 years of Drug Discovery experience in diabetes, pain and neurology. I have a strong track delivery record of science, project, people and budget management. My key strengths and experiences are in cross functional collaborations and business development between commercial and scientific partners. My key drivers are keen scientific curiosity and desire to find and aid in developing targets and enabling solutions that will have real benefit and impact on human health.Specialties:Drug Discovery and CRO servicesPeople and collaboration leaderStrategy and technology developmentProject, portfolio and executive management
Listed skills include Drug Discovery, Pharmacology, In Vitro, Neuroscience, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Solna, SE
As CEO I am responsible for developing the company as a high quality provider of Drug Discovery specialty services and developing the commercialization strategy together with the Board.
Solna, SE
Co-founder of Pelago Bioscience AB, established to enable Target Engagement studies using the CEllular Thermal Shift Assay method invention and develop the CETSA® technology platform
Cambridge, Cambridgeshire, GB
Developed and managed the early Neurology Portfolio in AstraZeneca CNSP iMed. Prioritizing and executing projects from Target Idea to Lead Generation based on disease area strategy, target validity and feasibility
A global cross functional effort and investment (> 25 FTE years, consumables overhead and a capital investment budget of several MUSD) aimed at facilitating and filling gaps in the AstraZeneca ion channel drug discovery value chain across all disease areas.
A scientific ladder appointment based on my specialist skills in electrophysiology and in vitro pharmacology with emphasis on screening platforms, technologies and methodologies including plate readers, automated imaging and electrophysiology and biophysical measurement platforms
Postdoctoral level position implementing new screening technologies, developing ion channel expertise, screening platforms and contributing with in vitro pharmacology and target validation data in several analgesia projects including one investigational candidate programme and one clinical programme (Phase IIb).
Oxford, Oxfordshire, GB
Structure function and in vitro pharmacology studies on ATP sensitive potassium channels involved in glucose sensing and insulin secretion from pancreatic beta-cells. From 2001 Robert Turner Visiting Scholar at Green College Oxford.
Bagsværd, DK
Functional and Molecular Characterization of ATP-Sensitive Potassium Ion Channels
Aarhus, DK
Functional and Molecular Characterization of ATP-Sensitive Potassium Ion Channels. I set up and used the macropatch recording technique for my studies and trained several other students in the technique.
Functional and Molecular Characterization of ATP-Sensitive Potassium Ion Channels
Quick answers generated from the profile data available on this page.
Michael Dabrowski works for Pelago Bioscience AB.
Michael Dabrowski is listed as CEO at Pelago Bioscience AB at Pelago Bioscience AB.
AeroLeads has found 1 work email signal at @pelagobio.com for Michael Dabrowski at Pelago Bioscience AB.
Michael Dabrowski is based in Nacka, Stockholm County, Sweden while working with Pelago Bioscience AB.
Michael Dabrowski has worked for Pelago Bioscience Ab, Astrazeneca, Astrazeneca R&D, Oxford University, and Novo Nordisk A/S.
You can use AeroLeads to view verified contact signals for Michael Dabrowski at Pelago Bioscience AB, including work email, phone, and LinkedIn data when available.
Michael Dabrowski holds Executive Leadership Programme, Business Administration And Management, General from Stockholm School Of Economics.
Michael Dabrowski is listed with skills including Drug Discovery, Pharmacology, In Vitro, Neuroscience, Ion Channels, Assay Development, Drug Development, and Electrophysiology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts